Literature DB >> 18052663

[Protocolized cognitive-behavioural group therapy for inflammatory bowel disease].

M A Díaz Sibaja1, M I Comeche Moreno, B Mas Hesse.   

Abstract

INTRODUCTION: patients affected by inflammatory bowel disease have a high rate of psychiatric disorders such as depression and anxiety.
OBJECTIVE: the main goal of this study was to design, to put into practice, and to validate a protocolized psychological treatment program based on the coping model, and a psycho-educational methodology in which the following intervention modules were included- illness information, coping model, problem solving techniques, relaxation, social skill training, distraction, and cognitive restructuring techniques. All these techniques were adapted to the characteristic features of inflammatory bowel disease.
METHOD: the sample included 57 patients with inflammatory bowel disease from the Spanish Crohn s Disease and Ulcerative Colitis Association. The sample was randomly assigned to one of the two experimental groups -33 were assigned to the treatment group, and 24 were assigned to the waiting list control group.
RESULTS: the results reflected a significant clinical and statistical improvement in anxiety (p < 0.001) and depression (p < 0.001) variables when compared to the waiting list control group. Likewise, improvement was sustained at 3, 6, and 12 months during follow-up.
CONCLUSION: the protocolized psychological treatment program, administered in group sessions, is effective in reducing emotional symptoms arising as a result of inflammatory bowel disease.

Entities:  

Mesh:

Year:  2007        PMID: 18052663     DOI: 10.4321/s1130-01082007001000006

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  12 in total

Review 1.  Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance.

Authors:  Whitney Duff; Natasha Haskey; Gillian Potter; Jane Alcorn; Paulette Hunter; Sharyle Fowler
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 2.  Comorbidity in inflammatory bowel disease.

Authors:  Antonio López San Román; Fernando Muñoz
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 3.  Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

Authors:  Branislav R Filipovic; Branka F Filipovic
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

4.  Treatment of psychological co-morbidities in common gastrointestinal and hepatologic disorders.

Authors:  Antonina A Mikocka-Walus
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-04-06

5.  Impact of depression and anxiety on the quality of life of constipated patients.

Authors:  Jenna J Albiani; Stacey L Hart; Laura Katz; Julia Berian; Amanda Del Rosario; Janet Lee; Madhulika Varma
Journal:  J Clin Psychol Med Settings       Date:  2013-03

6.  Beneficial Effects of Education on Emotional Distress, Self-Management, and Coping in Patients with Inflammatory Bowel Disease: A Prospective Randomized Controlled Study.

Authors:  Anja Berding; Christine Witte; Marion Gottschald; Birgit Kaltz; Romy Weiland; Christian Gerlich; Andrea Reusch; Wolfgang Kruis; Hermann Faller
Journal:  Inflamm Intest Dis       Date:  2016-11-30

7.  Psychological issues in inflammatory bowel disease: an overview.

Authors:  M S Sajadinejad; K Asgari; H Molavi; M Kalantari; P Adibi
Journal:  Gastroenterol Res Pract       Date:  2012-06-21       Impact factor: 2.260

8.  Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial.

Authors:  Antonina Mikocka-Walus; Peter Bampton; David Hetzel; Patrick Hughes; Adrian Esterman; Jane M Andrews
Journal:  BMC Gastroenterol       Date:  2015-05-02       Impact factor: 3.067

9.  Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases.

Authors:  Sarah Ballou; Laurie Keefer
Journal:  Clin Transl Gastroenterol       Date:  2017-01-19       Impact factor: 4.488

10.  The use of mindfulness-based cognitive therapy for improving quality of life for inflammatory bowel disease patients: study protocol for a pilot randomised controlled trial with embedded process evaluation.

Authors:  Mariyana Schoultz; Iain M Atherton; Gill Hubbard; Angus J M Watson
Journal:  Trials       Date:  2013-12-17       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.